Antibody guided lymphangiography in the staging of cervical cancer
Open Access
- 1 June 1985
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 51 (6) , 805-808
- https://doi.org/10.1038/bjc.1985.125
Abstract
Iodine-123-labelled tumour associated monoclonal antibody HMFG2 was administered intralymphatically at a time that cannulation of pedal lymphatic vessels was performed for standard lymphangiography in 6 patients with cervical cancer. Gamma camera images were taken at 2 h and 24 h after injection of antibody and at a similar time that X-ray lymphangiography was performed. Five out of the 6 standard lymphangiograms were reported as normal whilst one showed definite evidence of metastasis. Antibody guided analysis of the abnormal lymphangiogram confirmed the presence of abnormality. Also, marked non-specific uptake of antibody was seen on all lymphangiograms. It is concluded that, in order for monoclonal antibody guided lymphangiography to become a useful adjunct to standard lymphangiography, further improvements are needed to reduce non-specific uptake by normal lymphatics.Keywords
This publication has 6 references indexed in Scilit:
- LOCATION OF METASTATIC BREAST CARCINOMA BY A MONOCLONAL ANTIBODY CHELATE LABELLED WITH INDIUM-111The Lancet, 1983
- TARGETING OF IODINE-123-LABELLED TUMOUR-ASSOCIATED MONOCLONAL ANTIBODIES TO OVARIAN, BREAST, AND GASTROINTESTINAL TUMOURSThe Lancet, 1982
- Localization of I-131-Labeled Goat and Primate Anti-Carcinoembryonic Antigen (CEA) Antibodies in Patients with CancerInvestigative Radiology, 1982
- Differentiation antigens expressed by epithelial cells in the lactating breast are also detectable in breast cancersInternational Journal of Cancer, 1981
- THE ACCURACY OF LYMPHANGIOGRAPHY IN CARCINOMA OF THE UTERINE CERVIXAmerican Journal of Roentgenology, 1971